Across TCGA pan-cancer cohorts, RNA5SP408 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RNA5SP408 data layer.
The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNA5SP408 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP408 expression acts as an unfavorable survival marker.
STAD and CESC are the cancer types where RNA5SP408 RNA most reproducibly stratifies survival.